Indeterminate results of the second-generation hepatitis C virus (HCV) recombinant immunoblot assay: significance of high-level c22-3 reactivity and influence of HCV genotypes.

A second-generation recombinant immunoblot assay (RIBA 2.0) is used in the United States to confirm infection with hepatitis C virus (HCV) in samples that are anti-HCV (enzyme immunoassay) positive. In some cases, indeterminate results of RIBA 2.0, which are defined as reactivity to a single antigen...

Full description

Saved in:
Bibliographic Details
Main Authors: Zein, N N, Germer, J J, Wendt, N K, Schimek, C M, Thorvilson, J N, Mitchell, P S, Persing, D H
Format: Artigo
Language:Inglês
Published: 1997
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC229567/
https://ncbi.nlm.nih.gov/pubmed/8968936
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items